Girish N. Nadkarni, MD, MPH

Director, The Charles Bronfman Institute of Personalized Medicine

System Chief, Division of data-Driven and Digital Medicine
Mount Sinai Health System

Irene and Dr. Arthur M. Fishberg Professor of Medicine
Icahn School of Medicine at Mount Sinai

Girish Nadkarni is the Irene and Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai. As a physician-scientist, Nadkarni bridges the gap between comprehensive clinical care and innovative research. He is the system chief of the Division of Data-Driven and Digital Medicine (D3M), the co-director of the Mount Sinai Clinical Intelligence Center (MSCIC), and the director of the Charles Bronfman Institute for Personalized Medicine.

Before completing his medical degree in India, Nadkarni received training in mathematics. He then received a master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health and then was a research associate at the Johns Hopkins Medical Institute. Dr. Nadkarni completed his residency in internal medicine and his clinical fellowship in nephrology at the Icahn School of Medicine at Mount Sinai. He then completed a research fellowship in personalized medicine and informatics.

Nadkarni is the principal or co-investigator for several grants funded by the National Institutes of Health focusing on informatics, data science, and precision medicine. He is also one of the multiple principal investigators of the NIH RECOVER consortium focusing on the long-term sequelae of COVID-19.

Praduman “PJ” Jain

Founder and CEO – Vibrent 

Contact PI
NIH Precision Medicine Consortium & All of Us Research Program Technology Center 

Principle Investigator
NIH AIM-AHEAD Consortium & AI/ML to reduce health disparities and mitigate bias 

Praduman Jain, known to colleagues as “PJ,” is the CEO and founder of Vibrent Health and the principal investigator of the Participant Technology Systems Center of the National Institutes of Health’s All of Us Research Program. Under Jain’s leadership, the NIH awarded Vibrent $75 million in 2017 and an additional award in 2020 — with initial first-year funding of $39 million — to build and manage a national platform for health research for one million people across the US over the program’s expected span of 10 or more years. In 2020, Vibrent received more than $4 million in funds from the NIH to build next-generation technology for COVID-19 screening, testing, and contact tracing. Jain is also the chair of the security board of the Committee on Access, Privacy, and Security for the NIH All of Us Research Program. Before founding Vibrent, Jain held various senior leadership roles at Sprint, Nextel, AOL, Time Warner, and VTech and launched emerging products and services with revenues of more than $2 billion. He earned a Master of Science degree in electrical engineering, holds several patents, and has authored several research publications.